PaLM Conf Minutes 2016-Dec-14

From IHE Wiki
Jump to navigation Jump to search

Back to IHE Pathology and Laboratory Medicine (PaLM) Domain

Back to IHE Pathology and Laboratory Medicine (PaLM)Technical Committee Page


The recording for this meeting can be downloaded HERE


Francois Macary Phast
Raj Dash, Co-Chair CAP
Riki Merrick, Co-Chair APHL
Carolyn Knapik CAP, secretariat
Mary Kennedy CAP, secretariat
Alessandro Sulis CRS4
Dan Rutz Epic
David de Mena SAS
Dmytro Rud Roche
Filip Migom MIPS
Francesca Frexia CRS4
JD Nolen Cerner
Jurgen De Decker MIPS
Laurent Lardin bioMerieux
Megumi Kondo Sakura Finetek Japan


Agenda Review

1st hour

Announcement: Dmytro’s last meeting in PaLM – he is leaving Roche, staying in Healthcare, but not lab


F2F date for Japan: May 31 – June 2, 2017


Board report:

  • Still need to find a few numbers for the connectathons – Megumi to look up registry numbers for Japan Riki to send this out to the google group


Call for new proposals:

  • open until December 31st, 2016 – will review all proposals on our January committee call


SET document review:

  • Merged use cases between inter and intra-organizational organization transfer
  • Will a single diagram be enough, or do we need to add a second diagram to describe the different actors in the lab that touch the specimen for custody tracking – do we keep the pre-/post-processors?
  • Pre-and post-processor is not mandatory
  • How do we show different kinds of devices – analyzer or pre-/ post-processor, so combine these devices into a single actor “Laboratory Device”, and remove the redundant events, once this is done. The distinction between Analyzer, Pre/post-processor is just textual information, and can also be carried in the metadata of the event.
  • Specimen discharge and specimen archive (= post-processor)
  • Re-identification –person collecting tissue has access to the patient info – in the lab create a new number for bio-banking number – keeping a link to the original patient ID – but others do NOT have that access. Sometimes the de-identification occurs later or in some cases it does not happen, when the sample is helped indefinitely – to identify if biobank tissue has additional information for the clinical case (e.g. if there is cancer in the biobank sample, then the biobanking event is canceled) – but at some point de-identification could become total.
  • Need to decouple de-identification and re-identification – biobanking identifier vs clinical identifier – when each of these steps happen is described by the research protocol, everyone is different
  • Store both container ID and biobanking ID – container IDs across shipping orgs may not be unique, so we need to track both – important that vendors support MORE THAN ONE ID per biobanking specimen
  • Not in diagram, but have in text


APSR 2.0:

  • Shared the example XML file by Gunter
  • Procedure Step section tracks all procedures performed on specimen


Riki drops off at 10:00 AM ET


Next call is on January 11, same time.